Cat.#: ASSD-103
Description | DAPI is a blue fluorescent DNA stain which is cell permeant at high concentrations. This is a ready made 1mg/mL staining solution. It is recommended to dilute this solution 1:1000 with your desired buffer for a 1µg/mL working concentration. 0.1µg/mL-10µg/mL is the typical working concentration used in most applications. DAPI also available. |
Size | 1 mL, 5 mL, |
Applications | The product is commonly used for cell imaging, cell counting, cell sorting (based on DNA content), apoptosis analysis, and HCA (high content analysis). |
Chemical Name | 4',6-Diamidino-2-phenylindole dihydrochloride |
Molecule Weight | 350.24 |
Molecular formula | C16H15N5.2HCl |
CAS Number | 28718-90-3 |
Purity | >98% |
Form | Pale yellow solution |
Storage | Store at -20° C |
Shipping | Shipped at 4°C |
Important | When using this product for the first time, aliquot the DAPI ready-made solution and store at -20°C to avoid repeated freezing and thawing. Additionally, We strongly recommend storing this solution in the dark and away from light due to the compound's light sensitivity. |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ASSD-167 | Fura-2 AM (Cell permeant) (AC167) | 1 mg | inquiry |
ASSD-155 | Bromophenol blue (AC155) | 5g | inquiry |
ASSD-181 | Nitrofluorescein, Isomer 1 (AC181) | 1 g | inquiry |
ASSD-202 | 5(6)-Carboxytetramethylrhodamine (AC202) | 100 mg, 250 mg | inquiry |
ASSD-227 | Organo/Limonene Mount (AC227) | 100 ml | inquiry |
ASSD-122 | Fluorescent β2 antagonist [(±)-propranolol] (AC122) | 500 μg | inquiry |
ASSD-147 | Rhodamine phalloidin-TRITC (AC147) | 300 tests, 100μg | inquiry |
ASSD-206 | Eosine-5-isothiocyanate (AC206) | 50 mg | inquiry |
ASSD-228 | ImmunoHistoMount (AC228) | 30 ml | inquiry |
ASSD-173 | FITC-Dextran 70 (AC173) | 100 mg, 500 mg | inquiry |
We are committed to accelerating progress in stroke research and drug development.